The 3‑month return of +205.9% (vs S&P +196.3%) is the standout figure, demonstrating that NVTS has capitalized on a rapid acceleration in semiconductor demand while delivering returns that exceed even a high‑flying market index, which strengthens the case for momentum‑driven investors.
The long‑term premium is modestly vulnerable to a potential slowdown in automotive electrification spending; a 10% dip in OEM orders could trim NVTS's annualised return by up to 2.5%, eroding its edge over the S&P and compressing valuation multiples.
The 3.23% decline in institutional ownership combined with insider net selling (ratio 0.30) flags a potential divergence between market optimism and internal confidence; if these trends accelerate, they could presage a sharper correction, especially given the stock's historic -58.2% max drawdown.
The three‑year CAGR of 6.6% masks the recent 44.9% YoY revenue plunge; this discrepancy signals that any historic growth was driven by a narrow product cycle and is not sustainable without a clear pipeline revival.
The -190% operating margin translates to $87 M of operating loss on $46 M of sales, a scale that cannot be covered by current cash balances and will likely force the company to raise equity or debt, diluting shareholders and increasing financial risk.
The most notable profitability shift is the 92% reduction in financial leverage (EM), which has cut the negative ROE by more than 600 percentage points, suggesting management is actively managing debt levels to improve capital structure stability.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -26.4 | -254.7 | 0.09 | 1.13 | -19.8 | -19.5 | -23.4 |
| 2024 | -24.3 | -101.6 | 0.21 | 1.12 | -36.6 | -35.4 | -21.7 |
| 2023 | -38.2 | -183.0 | 0.16 | 1.28 | -27.5 | -27.0 | -30.0 |
| 2022 | 19.4 | 194.8 | 0.09 | 1.12 | -30.8 | -30.5 | 17.4 |
| 2021 | -233.0 | -643.3 | 0.08 | 4.51 | -24.2 | -24.0 | -51.7 |
| 2020 | 26.3 | -160.7 | 0.24 | -0.67 | -45.0 | -44.6 | -39.3 |
| 2019 | -649.0 | -1028.4 | 0.19 | 3.35 | -355.0 | -332.5 | -193.6 |
The -19.8% ROIC translates to a $1.98 loss for every $10 of capital employed; if the company cannot turn this metric positive within 12‑18 months, it risks exhausting cash reserves and may be forced into dilutive financing or asset sales.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 3978 | 153 | 29 | 125 | 258 | -76 |
| 2024 | 1709 | 103 | 61 | 98 | 71 | 93 |
| 2023 | 2230 | 168 | 119 | 80 | 187 | 100 |
| 2022 | 4091 | 268 | 88 | 124 | 206 | 150 |
| 2021 | 4546 | 335 | 127 | 35 | 136 | 326 |
| 2020 | 1494 | 153 | 128 | 22 | 166 | 115 |
| 2019 | 1938 | 219 | 151 | 191 | 272 | 97 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $500M | $57M | $444M | $6M | $-230M | $237M | $260M | $52M |
| 2024 | $390M | $42M | $348M | $7M | $-79M | $87M | $120M | $21M |
| 2023 | $486M | $105M | $381M | $9M | $-143M | $152M | $206M | $48M |
| 2022 | $425M | $41M | $381M | $7M | $-104M | $110M | $142M | $20M |
| 2021 | $296M | $230M | $66M | $7M | $-261M | $268M | $291M | $11M |
| 2020 | $49M | $121M | $-72M | $6M | $-33M | $39M | $47M | $6M |
| 2019 | $9M | $6M | $3M | $5M | $-1M | $6M | $8M | $4M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $-43M | $-1M | $195M | $-1M | $-44M | ||
| 2024 | $-59M | $-9M | $3M | $-7M | $-66M | ||
| 2023 | $-41M | $-6M | $90M | $-5M | $-46M | ||
| 2022 | $-44M | $-108M | $-6M | $-5M | $-49M | $-1M | |
| 2021 | $-42M | $-3M | $275M | $-2M | $-44M | ||
| 2020 | $-21M | $-0M | $54M | $-0M | $-21M | ||
| 2019 | $-18M | $-0M | $4M | $-0M | $-18M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net